Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Bloch Stephen M

JEFFS ROGER

Adair Jason

Instividual Trader/Investor   https://t.co/6XxJw5gfQN

** INFORMATIONAL PURPOSES ONLY *DO NOT TRADE OFF ANY OF MY INFORMATION**

Marc Lehman

Gold Star Family.  Leader "The Stockyard" Meetup Group (online Canslim meetings).  IPO Aficionado.  No tips, just education on stock market fishing.

Greg Morton

Research and idea generation largely focused on small & mid-cap biotech and special situations.

Dana Street Research

I have seen the stock market change people's lives! It can change yours too. Never Give Up! You may find my best stock ideas at: https://t.co/rqfRosoA4A

Liquidia Technologies Inc (LQDA) Stock Price, Analysis & Trade Signals